Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Aug 3, 2021, during market hours
10-Q filed Aug 3, 2021, 34 days after period end · 0001396814-21-000050
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $135.59M | $75.51M | $101.82M | $80.72M |
| Net Income | $19.08M | -$7.27M | $2.73M | $2.56M |
| EPS Diluted | $0.42 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.17 |
| $0.06 |
| $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.